Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kure

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Clinical & Translational Immunology|December 20, 2016
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary diseaseHanne Astrid Eide, Ann Rita Halvorsen, Vandana Sandhu, et al.
Acta Oncologica (Stockholm, Sweden)|July 28, 2015
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort studyKnut J Labori, Matthew H Katz, Ching W Tzeng, et al.
Plos One|August 29, 2014
Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesisLotte K Vogel, Mona Sæbø, Helle Høyer, et al.
Cancer Letters|June 11, 2005
GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancerRikke Hansen, Mona Saebø, Camilla Furu Skjelbred, et al.
BMC Cancer|October 16, 2007
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinomaAnders Lorentzen, Lotte K Vogel, Rikke H Lewinsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2019
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapyJ Hamfjord, T K Guren, O Dajani, et al.
Advances in Radiation Oncology|June 16, 2018
Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapyHanne A Eide, Ingerid Skjei Knudtsen, Vandana Sandhu, et al.
BMC Cancer|February 12, 2011
The level of claudin-7 is reduced as an early event in colorectal carcinogenesisJette Bornholdt, Stine Friis, Sine Godiksen, et al.
British Journal of Cancer|April 12, 2017
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII studyTormod Kyrre Guren, Maria Thomsen, Elin H Kure, et al.
Virchows Archiv : an International Journal of Pathology|November 15, 2017
Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancerArtur Mezheyeuski, Carina Strell, Ina Hrynchyk, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Clinical & Translational Immunology|December 20, 2016
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary diseaseHanne Astrid Eide, Ann Rita Halvorsen, Vandana Sandhu, et al.
Acta Oncologica (Stockholm, Sweden)|July 28, 2015
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort studyKnut J Labori, Matthew H Katz, Ching W Tzeng, et al.
Plos One|August 29, 2014
Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesisLotte K Vogel, Mona Sæbø, Helle Høyer, et al.
Cancer Letters|June 11, 2005
GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancerRikke Hansen, Mona Saebø, Camilla Furu Skjelbred, et al.
BMC Cancer|October 16, 2007
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinomaAnders Lorentzen, Lotte K Vogel, Rikke H Lewinsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2019
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapyJ Hamfjord, T K Guren, O Dajani, et al.
Advances in Radiation Oncology|June 16, 2018
Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapyHanne A Eide, Ingerid Skjei Knudtsen, Vandana Sandhu, et al.
BMC Cancer|February 12, 2011
The level of claudin-7 is reduced as an early event in colorectal carcinogenesisJette Bornholdt, Stine Friis, Sine Godiksen, et al.
British Journal of Cancer|April 12, 2017
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII studyTormod Kyrre Guren, Maria Thomsen, Elin H Kure, et al.
Virchows Archiv : an International Journal of Pathology|November 15, 2017
Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancerArtur Mezheyeuski, Carina Strell, Ina Hrynchyk, et al.
Pageof 9